Fig. 8From: Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram modelDecision curve analysis (DCA) for predicting 3-year MACE risk in the development (A) and independent validation cohorts (C) and the 5-year MACE risk in the development (B) and independent validation cohorts (D). The graph depicts the expected net benefit for each patient with respect to the risk for MACEs as predicted by the nomogram. With increasing model curve length, the net benefit increasesBack to article page